Simplex Trading
BIOA

Simplex Trading’s BioAge Labs BIOA Stock Holding History

Simplex Trading’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Sell
4,800
-300
-6% -$5.42K ﹤0.01% 5343
2026
Q1 		$89.2K Buy
5,100
+3,800
+292% +$73.2K ﹤0.01% 5223
2025
Q4 		$17.2K Sell
1,300
-146,000
-99% -$1.29M ﹤0.01% 6617
2025
Q3 		$866K Buy
147,300
+10,600
+8% +$49.6K ﹤0.01% 3203
2025
Q2 		$564K Buy
136,700
+15,800
+13% +$63.7K ﹤0.01% 3378
2025
Q1 		$454K Buy
+120,900
New +$559K ﹤0.01% 3490

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Simplex Trading's BIOA Position: Q2 2026 in Review

Simplex Trading increased its BioAge Labs (BIOA) stake by 1,936% in Q2 2026, buying an estimated $812K and bringing the position to 47,280 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Simplex Trading first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Simplex Trading held 47,280 shares of BioAge Labs worth $1.16M as of Q2 2026.
  • Simplex Trading bought 44,958 BioAge Labs shares in Q2 2026, an estimated $812K.
  • BioAge Labs made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2622 holding.
  • Simplex Trading first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.